These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 27005718)

  • 1. Surveillance of Quality of Medicines Available in the Nepalese Market: A Study from Kathmandu Valley.
    Gyanwali P; Humagain BR; Aryal KK; Pandit A; Acharya T; Bista B; Dhimal M; Karki KB
    J Nepal Health Res Counc; 2015; 13(31):233-40. PubMed ID: 27005718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Problems associated with substandard and counterfeit drugs in developing countries: a review article on global implications of counterfeit drugs in the era of antiretroviral (ARVs) drugs in a free market economy.
    Nsimba SE
    East Afr J Public Health; 2008 Dec; 5(3):205-10. PubMed ID: 19374325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substandard artemisinin-based antimalarial medicines in licensed retail pharmaceutical outlets in Ghana.
    El-Duah M; Ofori-Kwakye K
    J Vector Borne Dis; 2012 Sep; 49(3):131-9. PubMed ID: 23135006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of Drug in Health Facilities: A Cross-sectional Study.
    Karki KB; Dhakal N; Humagain B; Pandit A; Acharya T; Gyanwali P
    J Nepal Health Res Counc; 2021 Jan; 18(4):644-648. PubMed ID: 33510503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutical Regulatory Framework in Ethiopia: A Critical Evaluation of Its Legal Basis and Implementation.
    Suleman S; Woliyi A; Woldemichael K; Tushune K; Duchateau L; Degroote A; Vancauwenberghe R; Bracke N; De Spiegeleer B
    Ethiop J Health Sci; 2016 May; 26(3):259-76. PubMed ID: 27358547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilot study of essential drug quality in two major cities in India.
    Bate R; Tren R; Mooney L; Hess K; Mitra B; Debroy B; Attaran A
    PLoS One; 2009 Jun; 4(6):e6003. PubMed ID: 19547757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug Quality in South Africa: A Field Test.
    Lehmann A; Katerere DR; Dressman J
    J Pharm Sci; 2018 Oct; 107(10):2720-2730. PubMed ID: 29936204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cross-sectional analysis of falsified, counterfeit and substandard medicines in a low-middle income country.
    Khurelbat D; Dorj G; Sunderland B; Sanjjav T; Bayarsaikhan E; Damdinjav D; Dorj G; Jigjidsuren A; Lkhagvasuren O; Erdenetsetseg B
    BMC Public Health; 2020 May; 20(1):743. PubMed ID: 32434489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance for falsified and substandard medicines in Africa and Asia by local organizations using the low-cost GPHF Minilab.
    Petersen A; Held N; Heide L;
    PLoS One; 2017; 12(9):e0184165. PubMed ID: 28877208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substandard and counterfeit antimicrobials: recent trends and implications to key public health interventions in developing countries.
    Tadeg H; Berhane Y
    East Afr J Public Health; 2012 Jun; 9(2):85-9. PubMed ID: 23139963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of drug recalls and quality of pharmaceutical products in Nepal.
    Neupane A; Bastakoti M; Tamang S; Giri B
    BMJ Open; 2022 Jul; 12(7):e053479. PubMed ID: 35788073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does price reveal poor-quality drugs? Evidence from 17 countries.
    Bate R; Jin GZ; Mathur A
    J Health Econ; 2011 Dec; 30(6):1150-63. PubMed ID: 21917346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Cross-Sectional Investigation of the Quality of Selected Medicines for Noncommunicable Diseases in Private Community Drug Outlets in Cambodia during 2011-2013.
    Rahman MS; Yoshida N; Tsuboi H; Sokchamroeun U; Keila T; Sovannarith T; Kiet HB; Dararath E; Akimoto Y; Tanimoto T; Kimura K
    Am J Trop Med Hyg; 2019 Nov; 101(5):1018-1026. PubMed ID: 31516106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using VigiBase to Identify Substandard Medicines: Detection Capacity and Key Prerequisites.
    Juhlin K; Karimi G; Andér M; Camilli S; Dheda M; Har TS; Isahak R; Lee SJ; Vaughan S; Caduff P; Norén GN
    Drug Saf; 2015 Apr; 38(4):373-82. PubMed ID: 25687792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of German official medicines control laboratories in combating counterfeit medicines].
    Wiegard A; Heuermann M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1214-1220. PubMed ID: 28948293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cross-sectional investigation of the quality of selected medicines in Cambodia in 2010.
    Yoshida N; Khan MH; Tabata H; Dararath E; Sovannarith T; Kiet HB; Nivanna N; Akazawa M; Tsuboi H; Tanimoto T; Kimura K
    BMC Pharmacol Toxicol; 2014 Mar; 15():13. PubMed ID: 24593851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consumer choice between common generic and brand medicines in a country with a small generic market.
    Fraeyman J; Peeters L; Van Hal G; Beutels P; De Meyer GR; De Loof H
    J Manag Care Spec Pharm; 2015 Apr; 21(4):288-96. PubMed ID: 25803762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substandard and counterfeit medicines.
    Rassool GH
    J Adv Nurs; 2004 May; 46(3):338-9. PubMed ID: 15119344
    [No Abstract]   [Full Text] [Related]  

  • 20. Price variation among different brands of anticancer medicines available in hospital pharmacies of Nepal.
    Shrestha S; Poudel RS; Kc B; Poudel BK; Sapkota B; Sharma S; Khadka A
    J Pharm Policy Pract; 2020; 13():6. PubMed ID: 32266073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.